Therapy: Gastric CA: Trastuzumab which blocks the growth of her 2/neu positive cells which comprise some stomach cancers, and which has relatively mild side effects, has undergone successful clinical trials for a subset of patients with stomach (gastric) cancer. If the tumor expresses her 2/neu, it should respond to such a treatment.
Answered 10/27/2012
5.5k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question